Morphological and Functional Evaluation of Irvine-Gass Syndrome

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01504074

Enrollment

Registered

2012-01-05

Start date

2011-11-30

Completion date

Unknown

Last updated

2015-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irvine Gass Syndrome

Keywords

Irvine Gass syndrome, multimodal imaging, SD-OCT, CME secondary to cataract surgery, in vivo correlation of morphology and function

Brief summary

Purpose: To evaluate morphological and functional characteristics of Irvine Gass syndrome Methods: 30 patients suffering on Cystoid macular edema (CME) secondary to Cataract surgery will be observed and evaluated by fluorescein-angiography, SD-OCT, reading performance, contrast sensitivity and microperimetry in a fixed time schedule

Interventions

BEHAVIORALif needed (decided individually) either Acular eye drops, Ultracortenol eye drop or intravitreal triamcinolone injection

if prescribed: Ultracortenol/ Acular eye drops 3-4 times a day, if prescribed: singular intravitreal triamcinolone injection

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* \> 18 years * St.p Cataract surgery * able to read * informed consent * with fluorescein angiography and SD-OCT diagnosed Irvine Gass syndrome

Exclusion criteria

* \< 18 years * CME of other origin * diabetic macular edema

Design outcomes

Primary

Measure	Time frame
Reduction of central retinal thickness	3 months

Secondary

Measure	Time frame
Increase of Best corrected visual acuity	3 months

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026